European interventional oncology device procedure volumes and revenues will grow moderately, driven by an expanding patient population, rising patient and physician awareness, improved reimbursement leading to adoption of premium-priced devices, launch of new products, and increased physician training on interventional oncology procedures. However, increasing competition in all market segments, coupled with ongoing cost constraints in the region and the impact of the COVID-19 pandemic, will limit the pace of revenue expansion.  

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for interventional oncology devices in Europe across a 10-year period.


COVID-19 will have a negative impact on the interventional oncology  device market.

How will COVID-19 affect the different segments of the interventional oncology device market?

When will the market start to recover and at what pace will it do so?

Reimbursement will be an important factor in the adoption of interventional oncology procedures.

How do reimbursement policies vary among the different European countries covered?

How will different reimbursement policies impact the uptake of interventional oncology devices? 

Ablation therapy procedures will continue to grow for the liver, kidney, and lung cancer indications, while novel indications such as prostate and pancreatic cancer represent new opportunities for growth.

What are the advantages and disadvantages of each type of ablation device offered by competitors and how do these differences affect adoption for different indications?

What are the major demographic, economic, and local trend differences across Europe that impact the adoption of these devices?

Radioembolization spheres continue to represent the largest segment of the embolization particle market, although the microsphere and DEB markets will also experience growth over the forecast period.

How will outcomes of trials like SIRFLOX and FOXFIRE affect the adoption and usage of radioembolization spheres?

What factors are contributing to the growth of  the European microsphere and DEB markets?

How will the uptake of other embolization particles impact the PVA particle market?

How will the adoption of bioresorbable microspheres and DEBs impact the adoption of existing products?

Table of contents

  • Europe
    • Abstract
    • Executive Summary
      • COVID-19 Updates
      • Market Highlights
      • Competitive Highlights
      • Market Developments
      • End-User Insights
      • Geographies Covered
      • Procedures Covered
      • Products Covered
    • Key Report Updates
    • COVID-19 Analysis
      • Market Impact
      • Guidance and Recommendations
      • Major Market Forecast Changes and Assumptions
      • Competitive Impact
    • Interventional Oncology Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Product Portfolio Management
        • Clinical Data
        • Reimbursement
        • Mergers, Acquisitions, and Partnerships
        • Product Improvements and Innovations
        • Physician Training and Marketing
        • Distribution and Sales Network
      • Market Developments
    • Ablation Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • Radiofrequency Ablation Devices
        • Microwave Ablation Devices
        • Cryoablation Devices
        • Irreversible Electroporation Ablation Devices
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
    • Embolization Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • Embolization Particles
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Clinical Data
    • Accessory Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • Guide Catheter
        • Microcatheter
        • Angiography Catheter
        • Guidewire
        • Sheath
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Product Improvements and Innovations
    • Appendix
      • Abbreviations
      • Bibliography

Author(s): Bishwjit Ghoshal, MBA

Bishwjit Ghoshal is a senior analyst within the Cardiovascular Medtech Insights team at DRG (Part of Clarivate), specializing in interventional oncology and vascular access device markets. Bishwjit holds a Bachelor's degree in Pharmacy from the University of Delhi and an MBA in Pharmaceutical Marketing from the National Institute of Pharmaceutical Education and Research, Mohali. Follow Bishwjit on twitter: @Bishwjit_DRG


Related Reports

Interventional Oncology Devices | Medtech 360 | Market Insights | Japan

Despite short-term contraction caused by the ongoing COVID-19 pandemic, as well as delays in the availability of new technologies due to strict regu...

View Details

Interventional Oncology Devices | Medtech 360 | Market Insights | Asia Pacific

Despite the challenges posed by the ongoing COVID-19 pandemic, the Asia Pacific interventional oncology device market will see strong growth

View Details

Interventional Oncology Devices | Medtech 360 | Market Insights | Latin America

The Latin American interventional oncology device market will see moderate growth, driven by an increasing patient population, adoption of premium-priced devices, and the introduction of new dev...

View Details

Interventional Oncology Devices | Medtech 360 | Market Insights | Asia Pacific (Supplemental)

The Asia Pacific market for interventional oncology will expand through 2027, driven primarily by continued growth of cancer incidence, improving access to treat...

View Details